Molecule Details
| InChIKey | YLCFOHVAOBLAIK-HNNXBMFYSA-N |
|---|---|
| Compound Name | N-[(2S)-1-(azetidin-1-yl)propan-2-yl]-3-[2-(3,5-dimethoxyanilino)pyrimidin-4-yl]-1-methylpyrazole-5-carboxamide |
| Canonical SMILES | COc1cc(Nc2nccc(-c3cc(C(=O)N[C@@H](C)CN4CCC4)n(C)n3)n2)cc(OC)c1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 14 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.58 |
| Source | ChEMBL |
2D Structure
Activity Profile
Target Activities (14)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P43405 | SYK | Homo sapiens | Human | PF07714 PF00017 | 8.3 | IC50 | ChEMBL |
| P19525 | EIF2AK2 | Homo sapiens | Human | PF00035 PF00069 | 7.1 | IC50 | ChEMBL |
| P08922 | ROS1 | Homo sapiens | Human | PF00041 PF07714 | 7.0 | IC50 | ChEMBL |
| P36888 | FLT3 | Homo sapiens | Human | PF00047 PF07714 | 6.7 | IC50 | ChEMBL |
| P43403 | ZAP70 | Homo sapiens | Human | PF07714 PF00017 | 6.7 | IC50 | ChEMBL |
| P05771 | PRKCB | Homo sapiens | Human | PF00130 PF00168 PF00069 PF00433 | 6.6 | IC50 | ChEMBL |
| O15146 | MUSK | Homo sapiens | Human | PF01392 PF07679 PF13927 PF07714 | 6.6 | IC50 | ChEMBL |
| P17612 | PRKACA | Homo sapiens | Human | PF00069 | 6.3 | IC50 | ChEMBL |
| P16234 | PDGFRA | Homo sapiens | Human | PF07679 PF25305 PF07714 | 6.2 | IC50 | ChEMBL |
| P04629 | NTRK1 | Homo sapiens | Human | PF13855 PF16920 PF07714 PF18613 | 6.2 | IC50 | ChEMBL |
| Q99759 | MAP3K3 | Homo sapiens | Human | PF00564 PF00069 | 6.1 | IC50 | ChEMBL |
| P16591 | FER | Homo sapiens | Human | PF00611 PF07714 PF00017 | 6.1 | IC50 | ChEMBL |
| Q86Z02 | HIPK1 | Homo sapiens | Human | PF00069 | 6.1 | IC50 | ChEMBL |
| O60674 | JAK2 | Homo sapiens | Human | PF18379 PF18377 PF17887 PF07714 PF21990 | 6.0 | IC50 | ChEMBL |